Therapeutic Targeting of miR-21 Restores SASH1 and Sensitizes HBV-HCC to Sorafenib
靶向 miR-21 的治疗可恢复 SASH1 并增强 HBV-HCC 对索拉非尼的敏感性
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18061038
Han, Kyuyoung; Jwa, Eun-Kyoung; Ha, Suhyeon; Kim, Jiye; Lee, Ryunjin; Lee, Eunkyeong; Kang, Seoon; Kim, Hye Ok; Kwon, Hyunhee; Jung, Dong-Hwan; Yoon, Young-In; Song, Gi-Won; Park, Gil-Chun; Kim, Tae Won; Namgoon, Jung-Man; Hwang, Shin; Tak, Eunyoung; Lee, Sung-Gyu